Artificial intelligence (AI) is being recognized as a crucial tool in addressing aging and chronic diseases, with the European Union seeking closer research collaborations with South Korea in this area. Luke O’Neill, a member of the European Research Council, highlighted that AI can significantly enhance disease diagnosis and accelerate drug discovery. As the U.S. research landscape shifts, Europe aims to attract global talent through programs like Horizon Europe, which South Korea joined last year. O’Neill emphasized that AI could revolutionize medical research by enabling deeper insights into complex biological systems, while urging young Korean researchers to engage in this promising field.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.koreaherald.com/article/10702481
